In November 2025, the White House announced that drug manufacturers, Eli Lilly (makers of Zepbound and Orforglipron) and Novo Nordisk (makers of Ozempic and Wegovy), will substantially reduce the price of weight loss medications under the Most Favored Nation (MFN) policy that requires that the United States pay no more for prescription medications than the […]
